With Mpox Vaccine In Serum Institute Pipeline, What Could Favor India Vaccine Makers?

Serum Institute is working on an mpox vaccine while other Indian firms are weighing options after the WHO sounded an alert and a new case was reported in neighboring Pakistan. Scrip looks at factors that could favor development and/or manufacture of an mpox vaccine at Indian majors.

Stepping Up To Bat
Can Indian Firms Step Up To The Plate With An Mpox Vaccine? • Source: Shutterstock

India could step up to the plate with a vaccine to prevent mpox, classified as a public health emergency of international concern (PHEIC) once again post 2022 by the World Health Organization (WHO) after a new clade Ib variant of the virus emerged this year.

More from India

More from Focus On Asia